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CARDIOLOGY/ORIGINAL RESEARCHVolume -, no.Exploring Patient Experience of Chest Pain
Before and After Implementation of an Early
Rule-Out Pathway for Myocardial Infarction:
A Qualitative Study
Amy V. Ferry, PhD*; Fiona E. Strachan, PhD; Stacey D. Stewart, MN; Lucy Marshall, MSc; Kuan K. Lee, MD; Atul Anand, MD, PhD;
Anoop S. V. Shah, MD, PhD; Andrew R. Chapman, MD, PhD; Nicholas L. Mills, MD, PhD; Sarah Cunningham-Burley, PhD
*Corresponding Author. E-mail: amy.ferry@ed.a.cuk.Study objective: High-sensitivity cardiac troponin assays enable myocardial infarction to be excluded in the emergency
department (ED). As part of a prospective clinical trial, we explore how introducing an early rule-out pathway may affect patient
experience of chest pain.
Methods: In a qualitative study, participants presenting to the ED with suspected acute coronary syndrome, and for whom the
diagnosis of myocardial infarction was excluded, were interviewed before (n¼23) or after (n¼26) implementation of an early rule-
out pathway. Preimplementation, diagnosis of myocardial infarction was excluded on serial troponin testing requiring admission to
the hospital. Postimplementation, diagnosis could be excluded in the ED, enabling direct patient discharge. Semistructured
interviews exploring the patients’ illness experience were conducted approximately 1 week postdischarge, transcribed verbatim,
and analyzed thematically. Themes emerging pre- and postimplementation are described.
Results: Common themes emerged across both pathways: participants commonly sought health care advice before presenting to
the ED; a discordance may exist between the objective interpretation of troponin results by clinicians and the patients’ experience
of illness; and pretest information, trust in the clinician, and active listening may enhance reassurance gained from negative test
results. Other themes related to the care pathway were that routine care procedures appeared to be a source of frustration for
participants requiring hospital admission, and patients assessed with the early rule-out pathway appeared less likely to appraise
their future health status.
Conclusion: The early rule-out of myocardial infarction may be enhanced by recognition of patient out-of-hospital experience and
improved communication surrounding reassurance and future cardiovascular health goals. [Ann Emerg Med. 2019;-:1-12.]
Please see page XX for the Editor’s Capsule Summary of this article.0196-0644/$-see front matter




Patients with suspected acute coronary syndrome are
responsible for 6% of emergency department (ED)
presentations.1 The majority of these patients will not
receive a diagnosis of myocardial infarction,2 but clinical
guidelines have recommended serial cardiac troponin-
level testing to safely rule out the diagnosis, which often
requires admission to the hospital.3,4 Because EDs are
under increasing pressure to reduce the number of
patients admitted to the hospital,5 the use of high-
sensitivity troponin assays to exclude myocardial- : - 2019infarction earlier or at presentation may increase
efficiency in the ED setting.
Importance
The European Society of Cardiology and the
National Institute for Health and Care Excellence have
endorsed early rule-out pathways based on high-
sensitivity cardiac troponin assays.6,7 The Food and
Drug Administration has now also approved high-
sensitivity cardiac troponin assays for clinical use. A
number of strategies have been proposed to identify
patients at presentation or 1 to 2 hours afterAnnals of Emergency Medicine 1
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What is already known on this topic
Some emergency departments (EDs) are using rapid
myocardial infarction rule-out pathways to avoid
hospitalization of patients with potential acute
coronary syndrome.
What question this study addressed
This qualitative study assessed patient impressions
before and after implementation of an ED rapid rule-
out pathway. Forty-nine patients were interviewed 1
week postdischarge and 5 major themes emerged
across both pathways.
What this study adds to our knowledge
A discordance may emerge between physician relief at
the absence of acute coronary syndrome according to
normal troponin levels and patient concern for
continued unexplained chest symptoms. Patients may
also be less likely to assess their health behaviors and
risk of future cardiovascular disease.
How this is relevant to clinical practice
Understanding patient perceptions may help
physicians provide better care for ED patients with
similar diagnostic trajectories.presentation who may be suitable for discharge directly
from the ED.8-14 Although the adoption of these rule-out
pathways could improve efficiency in the ED and therefore
lead to major benefits for health care providers, patients will
spend less time within the health care setting and may have
fewer assessments from specialists and opportunities to
discuss the nature of their symptoms, and as a consequence
may be less likely to be reassured their symptoms are
benign. Previous research into the experience of patients
with acute chest pain who present to the ED has shown
that they may be discharged with unanswered questions,15
feelings of uncertainty,16 and the need to feel more
supported after discharge.17
Goals of This Investigation
In this qualitative study embedded into a prospective
clinical trial,18 we aimed to explore the experience of 2
groups of patients undergoing assessment for suspected
acute coronary syndrome before and after
implementation of an early rule-out pathway for
myocardial infarction to identify how the assessment
pathway affects the patients’ experience. The insights2 Annals of Emergency Medicinerevealed will ensure that early rule-out pathways can be
applied to patient assessment in a way that responds to
patients’ needs.MATERIALS AND METHODS
Study Design and Setting
This qualitative study was embedded into a clinical trial
evaluating the safety and efficacy of an early rule-out
pathway for myocardial infarction across secondary and
tertiary care hospitals in Scotland.18 The qualitative
component was conducted at the lead site in the ED of the
Royal Infirmary of Edinburgh, a tertiary care hospital. The
clinical trial was approved by the national research ethics
committee and conducted in accordance with the
Declaration of Helsinki. This qualitative substudy was
prespecified in the trial protocol.Selection of Participants
Patients with suspected acute coronary syndrome were
recruited from the ED between March 2015 and June
2017. Patients older than 18 years, for whom the attending
clinician requested cardiac troponin-level testing for
suspected acute coronary syndrome, and who were
discharged on the basis of a negative evaluation result for
myocardial infarction were eligible for inclusion. Eligibility
was verified with the electronic patient record. The main
trial recruited consecutive patients, but the substudy used
purposive sampling to ensure representation across age and
sex categories (male patients, female patients, >65 years,
and 65 years). In a clinical scenario, the pathway is
applied nonselectively to any patient presenting with
symptoms suggestive of acute coronary syndrome. It was
therefore thought important that a broad spectrum of
patients be recruited to this study; therefore, participants
were not stratified further. Sampling and recruitment
occurred deliberately slowly to allow concurrent data
collection and analysis.
The early rule-out pathway was implemented on
February 15, 2016. Before this date, patients were admitted
to a medical assessment unit or cardiology ward for serial
troponin-level testing to determine peak troponin level at
10 to 12 hours after symptom onset. Eligible participants
were those discharged in accordance with negative serial
test results for myocardial infarction. Follow-up care was at
the discretion of the assessing clinician. After this date,
myocardial infarction was excluded in accordance with
troponin concentration at presentation or at 3 hours,
enabling patients to be discharged directly from the ED.19
Follow-up care remained at the discretion of the assessing
clinician. The postdischarge care of patients with theVolume -, no. - : - 2019
Figure 1. Summary of chest pain pathway and identification of
eligible participants. A, Before implementation of the early rule-
out pathway. B, After implementation of the early rule-out
pathway. GRACE, Global Registry of Acute Coronary Events;
AMU, acute medical unit.
Figure 1. (continued).
Ferry et al Patient Experience of Chest Painrule-out of myocardial infarction was not altered by the
implementation of the early rule-out pathway.
Identification of study participants according to pathway is
shown in Figure 1A and B.
The early rule-out pathway was developed in a substudy
of patients presenting with suspected acute coronary
syndrome between June 1, 2013, and September 30, 2015.
Blood samples were obtained at presentation and at 6 to 12
hours after symptoms onset for high-sensitivity cardiac
troponin-level testing as part of routine clinical care.
Patients provided informed consent to obtain an additional
blood sample at 3 hours as previously described.19,20 TheVolume -, no. - : - 2019troponin assay used was the Abbott ARCHITECTSTAT
high-sensitivity cardiac troponin I assay (Abbott
Laboratories, Abbott Park, IL).21 The upper reference limit
99th centiles were determined in 4,590 samples from
healthy individuals as 16 ng/L for women and 34 ng/L in
men.22Data Collection and Processing
Participants were approached by A.V.F. or an ED
research nurse with an information sheet while in the ED
or medical assessment unit (for those recruited in the
preimplementation phase). Participants were contacted by
telephone at least 24 hours after discharge to discuss
participation and arrange a date for interview 1 week
postdischarge if appropriate to do so. After written
informed consent was gained, interviews were conducted in
a place of the participants’ choosing, including their own
home (16 pre- and 21 postimplementation), the hospital (5
pre- and 2 postimplementation), or a private meeting roomAnnals of Emergency Medicine 3
Figure 2. Communication interventions aiding the
development of reassurance.
Patient Experience of Chest Pain Ferry et alat their workplace (2 pre- and 3 postimplementation). For
the majority of interviews, only the interviewer and
participant were present, although a family member was
present during 5 interviews.
A research diary was kept to document reflections after
each interview, and regular debriefing with a supervisor
(S.C.-B.) was used to promote researcher reflexivity.23 This
also served as a decision trail to demonstrate how
interpretative analysis evolved during the study and
therefore increased the trustworthiness of the study.24
Interviews lasted between 18 and 88 minutes. Data
collection and analysis occurred concurrently. Recruitment
continued until saturation was achieved and additional
interviews did not yield new insights.25
A female cardiology research nurse with experience in
qualitative interviewing techniques (A.V.F.) conducted
semistructured, detailed interviews, using a topic guide
developed from a literature review and clinical experience of
the study team (Appendix E1, available online at http://
www.annemergmed.com). The interviews proceeded as a
guided conversation, ensuring the same range of topics was
covered yet allowing respondents flexibility in how they
answered and in introducing new issues as relevant to them.
A.V.F. was not involved in the clinical care of patients and
was introduced to participants as a researcher. If
participants questioned the interviewer directly, her
identity as a nurse was revealed. Interviews all started with
the same opening question: “Could you tell me what
happened to take you into [the] hospital last week?”
Interviews were audio recorded and transcribed verbatim
by a professional transcription company. Each transcript
was checked for accuracy against the audio file by A.V.F.
Data are presented as quotes from transcripts, with “I”
prefixing interviewer speech and “P” participant speech.Primary Data Analysis
This study was guided by broadly phenomenological
principles,26 aiming to uncover the meaning and relevance
of experience. An interpretive approach was used to analyze
data thematically,27 using abductive reasoning, which seeks
to identify meaning from the accounts in iteration with
previous knowledge from the field.28 This involves
repeatedly reading and interpreting accounts to search for
patterns of meaning in the data. Data were coded by A.V.F.
under the guidance of an experienced senior qualitative
researcher (S.C.-B.). Interviews were read multiple times,
and relationships between codes were explored to identify
themes that were derived from the data. The grouping of
codes into themes was performed through discussion with
S.C.-B., including review of the patient narratives and4 Annals of Emergency Medicinecoding categories. Through this process, the themes and
model were created (Figure 2). Themes arising within
patient accounts from both pathways were compared to
search for similarities and differences in which the chest
pain pathway may be implicated. Data were managed with
NVivo (version 10; QSR International, Victoria, Australia).
When clear differences between care pathways were
observed, the results were quantified. When themes were
pervasive across both pathways, quantification of results did
not add value to the analysis.RESULTS
Characteristics of Study Subjects
One hundred forty-three patients were approached with
an information sheet; 23 participants were interviewed
before and 26 participants after implementation of the early
rule-out pathway. Reasons for nonparticipation are
outlined in Figure 3. The mean age of men was 59 years
(SD 14 years) preimplementation and 60 years (SD 15
years) postimplementation, and for women it was 58 years
(SD 15 years) preimplementation and 61 years (SD 15
years) postimplementation. The median length of hospital
stay was 10.5 hours (interquartile range 8.2 to 12.3 hours)
and 3.4 hours (interquartile range 2.5 to 3.9 hours) before
and after implementation of the early rule-out pathway,Volume -, no. - : - 2019
Figure 3. Reasons for nonparticipation of potential study participants.
Ferry et al Patient Experience of Chest Painrespectively. Further details of study participants are
reported in Table 1.
Main Results
Five important concepts could be identified in the
accounts of participants interviewed both before and after
implementation of the early rule-out pathway. Where
variance in response was noted between pathways, these
differences have been highlighted.
First, it was rare for a patient to make the decision to
attend the hospital for assessment independently without
previous contact with the health service. Participants
revealed a careful consideration about their personal
justification to use the health service, resulting in their
seeking confirmation that their symptoms warranted
professional health care assessment. Only 7 of 49 patients
attended the ED without consulting a second party. Many
patients (61% [30/49]) had sought advice from a general
practitioner or NHS 24 (a telephone advice and triage
service that runs out of hours in Scotland), with the
recommendation to attend the hospital for assessment, or
the even stronger message of “telephone 999” (the
equivalent of 911 in the United States). The remainder of
patients consulted lay networks for advice. It was alsoVolume -, no. - : - 2019apparent in several transcripts that receiving advice from a
general practitioner or NHS 24 call handler to attend the
ED for assessment may actually strengthen patients’ belief
that their symptoms are serious. This is illustrated through
participant quotes in Table 2.
Second, and also common to participants assessed both
pre- and postimplementation of the early rule-out pathway,
a discordance between the objective interpretation of a
troponin concentration by a clinician and the ongoing
illness episode experienced by the patient was illustrated.
Patient accounts revealed that, although a medical
consultation may have concluded for the clinician with a
negative evaluation result for acute coronary syndrome and
a perception that reassurance had been provided, for some
patients, their illness episode was still very much ongoing at
the subsequent interview, whichever clinical pathway they
had followed. A discordance was therefore found to exist
between the objective interpretation of a troponin value by
the clinician and the significance that result held to the
patient in the context of his or her illness experience. When
the pathway, driven by the high negative predictive value of
a low troponin concentration, reassured the clinician that
the patient did not warrant further investigation (inferred
by the decision to discharge the patient), for some patients,Annals of Emergency Medicine 5
Table 1. Baseline characteristics of study population.
All Preimplementation Postimplementation
Study sample
Participants, No. (% women) 49 (45) 23 (39) 26 (50)
Women >65 y, No. (%) 12 (25) 4 (18) 8 (31)
Women 65 y, No. (%) 10 (20) 5 (22) 5 (19)
Men >65 y, No. (%) 16 (33) 7 (30) 9 (34)
Men 65 y, No. (%) 11 (22) 7 (30) 4 (16)
Men, age, y
Mean (SD) 60 (14.4) 59 (4.4) 60 (14.9)
Range 20–85 33–85 20–83
Women, age, y
Mean (SD) 59 (14.6) 58 (15.2) 61 (15.3)
Range 35–82 35–72 41–82
Medical history, No. (%)
Smoking 20 (41) 11 (48) 9 (35)
Diabetes mellitus 6 (12) 4 (17) 2 (8)
Hypertension 22 (45) 9 (39) 13 (50)
Hyperlipidemia 19 (39) 9 (39) 10 (38)
Family history 25 (51) 14 (61) 11 (42)
Angina 11 (22) 5 (22) 6 (23)
Myocardial infarction 15 (31) 9 (39) 6 (21)
Previous PCI 11 (22) 7 (30) 4 (15)
Previous CABG 2 (4) 1 (4) 1 (4)
Heart failure 0 0 0
Cerebrovascular disease 0 0 0
Peripheral vascular disease 1 (2) 0 1 (4)
Length of stay, median (interquartile range), h —* 10.5 (8.2–12.3) 3.4 (2.5–3.9)
PCI, Percutaneous intervention; CABG, coronary artery bypass graft.
*Dash indicates value not calculated
Patient Experience of Chest Pain Ferry et althis reassurance was not perceived despite clinical notes
stating that reassurance had been given. Some patients left
the hospital without a satisfactory conclusion to their illness
episode, with ongoing questions about the cause of their
pain and some patients still believing that their pain may
have had a cardiac substrate. Participant quotes provide
illustrations in Table 2.
Third, common to both pathways and suffusing the
interviews, was the theme of “reassurance,” which appeared
both implicitly and explicitly. When discordance as
described above was present, reassurance appeared much
more difficult to achieve. An initial code of “completed
interaction,” signifying that the patient perceived that the
health care encounter had come to an end, was used to
conceptualize the meaning of reassurance in a clinical
context. Data arising from the interviews suggest that
reassurance is a process that has to be built atop certain
foundations laid during the clinical assessment. Reassurance6 Annals of Emergency Medicinewas more apparent within patient accounts if an alternative
diagnosis about the cause of the chest pain was offered, if the
participant was referred for outpatient investigations
signaling ongoing care, or if the participant had a very low
level of concern that the pain may have had a cardiac cause.
For participants who did believe their pain could be cardiac
in nature, the development of reassurance was influenced by
3 contributing factors: timing of information giving, patient-
clinician interaction, and the development of trust. These
factors all involve effective communication between the
patient and clinician. Providing information about troponin
testing and the possible meaning of results before actual
testing appeared to relate to positive expressions of
reassurance within interviews. Evidence of the clinician’s
using active listening that acknowledged the patients
concerns also enabled trust in the clinician to develop. When
the factors of pretest information, active listening, and trust
were satisfied, participant perception of closure of the acuteVolume -, no. - : - 2019




I: So why NHS 24?
P: That was.I don’t know. That was.to me, that’s a step before you phone 999 for an
ambulance. Erm, and then you’re giving somebody else the decision to.
I: Yes.
P: .[I]f, though.if they think it’s serious enough, then I, I.I’m wary about taking up
people’s time, et cetera..
I: Okay.
P: .[I]f it’s, you know, not warranted, sort o’ thing.
Participant 19, >65 y, woman
(preimplementation)
P: Well, it’s, it was certainly, um, again, I mean, it was one of these situations where, you
know, I had to phone up and the receptionist said, “Is it an emergency,” and I said,
“Well, all I can tell you is this is what’s happened..”
I: Yeah.
P: .[T]his has been my experience, and she said.so she made the de-decision, the
receptionist made the decision.[to telephone an ambulance].
I: Right.
P: .[W]hich was great because I didn’t want to be wasting the, the GP’s [general
practitioner’s] time..
Participant 38, 65 y, man
(postimplementation)
I: So when you got the advice to attend A&E.
P: Mm-hmm.
I: .[H]ow did you feel about that?
P: Oh, that.that.it.it then went from “I’ve got a pain in my chest” to “I’ve got a pain in
my chest and someone thinks that my symptoms are serious.”
I: Right.
P: Um, so it.it escalated a wee bit. So I went from thinking, well, maybe there’s something
wrong to, well, it’s maybe more than a maybe.
Participant 49, >65 y, man
(postimplementation)
Discordance I: I’d like to explore the reason why you don’t feel you can go out.
P: I just thought.I think.I just thought I got such a fright, really.
I don’t know if I still thought I could see me having a heart attack..
Participant 5, >65 y, woman
(preimplementation)
P: At the time they told me I could go home, that felt good.. I know there’s a bigger
picture.
Participant 11, 65 y, man
(preimplementation)
P: I just know there is something going on. Whether it’s my heart or not I don’t know. Participant 38, 65 y, man
(postimplementation)
P: At the back of my mind you’re thinking is this my heart? Am I going to have a heart
attack?
Participant 48, 65 y, woman
(postimplementation)
Reassurance P: There was absolutely no damage to my heart. Participant 2, >65 y, woman
(preimplementation)
P: I feel quite confident about my heart now because of the tests. I’ve no concerns about
my heart.
Participant 15, >65 y, man
(preimplementation)
P: Once I was discharged with a clean bill, I parked it. Participant 24, 65 y, man
(postimplementation)
Ferry et al Patient Experience of Chest Painillness episode could be observed in interviews. This model is
presented in Figure 2. Participant quotes provide illustrations
in Table 2.
The standard assessment procedures carried out by
hospital staff could be interpreted by patients in a manner
different from that intended. The efficiency and speed with
which ED staff carried out initial assessment procedures were
interpreted by some participants as confirmation that their
symptoms were a cause for concern. Likewise, the routine
nature of repeated blood sampling for peak troponin level as
required by the preimplementation pathway could also beVolume -, no. - : - 2019interpreted by participants to signify a higher likelihood that
their symptoms may have been due to myocardial infarction.
Additionally, some participants spoke in terms of being part
of a “process.” For some participants, the routine nature of
the assessment process was evidence that clinicians would
perform appropriate actions because they were following a
protocol. For others, the protocol-driven actions were
interpreted as lack of personalized care.
Expressions of negativity concerning ambiguity in regard
to an overnight admission to the hospital and the need to
repeat a symptom history to multiple practitioners wereAnnals of Emergency Medicine 7




P: The only thing that I’ve found a bit irritating was the inconsistency of the doctors when I
got in there. You’re going home. You’re staying in. You’re going home. You’re staying in.
So there was 3 different doctors, told me different things.
Participant 4, >65 y, woman
(preimplementation)
P: It was frustrating, you know, to have to tell the nurse what had happened, and then
frustrating to have to tell someone else what had happened, and then a doctor what had
happened, and then the consultant what had happened; you know what I mean. So
there was, I was thinking, Jesus, can we not just get everybody in the room, and I’ll tell
you, look, here is what happened, guys.
Participant 23, 65 y, man
(preimplementation)
P: And, uh, then a lady came back and then she said I needed to take an aspirin and I
would need to stay in till after 12 to get another blood test, because it...she said if it was
the heart and any damage had been done, this test showed up something that’s
released into the blood. Um, and then I thought, oh, no. Then it was...slight panic set in,
because I thought, it’s not as straightforward as I thought. What if they’ve found
something?
Participant 14, >65 y, man
(preimplementation)
P: If, if the emergency department are going through their protocols, then clearly that’s
their protocols for, for that. If, however, there is, something that’s flagging up, then I
think it should either be referred back to the GP [general practitioner] to take up.or
sent to whoever needs to make, you know, the decisionmaker. I think not being listened
to is critical.




P: Now, for me, I would have said, I’m 53, history of.aged myself prematurely here.um,
you know, cardiac problem history in the family, overweight, don’t smoke and things, so
those are the risk factors, aren’t they? But I would have probably seen that as an
opportunity to say, okay, you’ve maybe had a bit of a scare here; these are the things you
should look out for if this happens again. Because there was none of that advice, in
terms of, right, if.this is what you.so if this pain happens again, that’s okay, ’cause
that’s just your frozen shoulder, but these are the, the warning signs you should maybe
look out for, or these are the things you should be doing to reduce your risk of
heart.problems, or even go and see your GP [general practitioner] for a general
checkup..
Participant 20, 65 y, woman
(preimplementation)
P: Well, it wasn’t a heart attack this time. Will there be a heart attack next time? You know,
that, that’s my concern. Um, I need to change some lifestyle things which I know about,
and I will, I am. Um, but I need to also get to the, the root cause of the stress, and
anxiety bit, which is work related.
Participant 11,
65 y, man (preimplementation)
Patient Experience of Chest Pain Ferry et alcommon in interviews of participants assessed before
implementation of the early rule-out pathway (78%; 18/
23) but less so in those assessed after its implementation
(15%; 4/26). These interpretations are illustrated through
participant quotes in Table 3.
The final theme, and where a further difference was
observed between chest pain pathways, was the way in
which participants made use of their acute chest pain
presentation to the hospital as an opportunity to consider
their future heart health. “Approaches to future health” was
an unelicited theme within interview transcripts.
Participants demonstrating an awareness of future heart
health did so in 3 main ways. First, they discussed their
incentive to modify their lifestyle as a result of an acute
chest pain admission. Second, some participants suggested
their acute chest pain presentation and assessment was an
appropriate opportunity for health promotion activities.
Third, some participants discussed how the rule-out of
myocardial infarction related to their overall heart health8 Annals of Emergency Medicineand their future susceptibility to heart disease. Some
patients made no reference to their future health during the
course of the interview. This analysis has consequently
revealed 3 possible perspectives by which participants may
relate to their future health status. For some participants,
continuing good health was taken for granted and therefore
did not have particular salience in their everyday lives. For
others, the way in which they reacted to the chest pain
episode varied in accordance with their position in the adult
life course and their current health status. For example,
their current health status because of comorbidities
appeared to have dominance over the acute chest pain
episode, leading to discourses of fatalism and certainty of
future ill health. Other participants used the chest pain
presentation, and therefore the recognition of a physical
manifestation of ill health, as a trigger to appraise health
behaviors and assess their future risk of cardiovascular
disease. This aspect was more commonly observed in
patients interviewed before implementation of the earlyVolume -, no. - : - 2019
Ferry et al Patient Experience of Chest Painrule-out pathway (43% [10/23] preimplementation versus
19% [5/26] postimplementation). Participant quotes
provide illustrations in Table 3. Additional illustrations for
all themes are shown in Table E1 (available online at http://
www.annemergmed.com).LIMITATIONS
Our sample was limited to patients assessed in a single
ED in Scotland and therefore may not represent the views
of more diverse populations, particularly in regard to
ethnicity. One of the main reasons for nonparticipation was
prospective participants’ not returning the screening
telephone call. However, despite challenges to recruitment
in health-related research, recruitment rates to this study
were typical of other clinical trials.29 It is possible that
participants agreeing to be involved in this study were
patients who were more likely to have ongoing health
concerns. It is likely that this study population did not
include patients who were fully reassured by the assessment
process and did not view themselves as having continuing
care needs or unanswered questions because such
participants may well have thought that they would gain
little from being part of the research process. Conducting
interviews 1 week postdischarge could influence the
content of participant accounts because of events occurring
during the recovery period. However, many patients do not
process their illness experience until after discharge from
the hospital, with concerns becoming apparent only after
the acute event. With patients spending less time in the
hospital when assessed with the early rule-out pathway, it
was believed important to capture how this period may
have been influenced by implementation of the early rule-
out pathway. We also acknowledge that previous illness
experience could affect how participants interpreted
information and events during the chest pain assessment
process. For some participants, returning to the hospital for
a research interview appeared to be used as a further
opportunity for contact with a health care practitioner.
Although we acknowledge that the study population may
represent those who are more concerned about their heart,
it is these very patients who require continued support.
Potential biases may also exist in selection of participants
and coding, although efforts were made to reduce these
potential effects. Initial identification of potential
participants was performed by nurses from the ED research
team, who were not involved with any other aspect of the
study and were unaware of the emerging themes of the
research. Participant selection could not therefore be
influenced by emerging study data. Additionally, because
data collection and analysis occurred concurrently, blindingVolume -, no. - : - 2019to study group was not possible. All interviews were
conducted by A.V.F., although interview technique was
discussed and transcripts were reviewed with an
experienced senior colleague (S.C.-B.). The grouping of
codes into themes was performed through discussion with
S.C.-B., including a review of the patient narratives and
coding categories. Throughout the process of data
collection and analysis, researcher reflexivity was used to
discuss any possible biases.DISCUSSION
In this study, we explored patient experience of chest
pain in 2 groups of patients assessed before and after the
implementation of an early rule-out pathway for
myocardial infarction. Using individual patient interviews
allowed participants to describe their experiences in their
own words, thereby providing data that would not be
captured with quantitative data collection methods. This
study adds to a prospective questionnaire study of patients
admitted to a short-stay ward with symptoms of suspected
acute coronary syndrome, in which closed questions were
posed about the acceptability of an early discharge pathway
at patient discharge.30 These methods may not capture the
richness of experience, not least because many patients do
not process their illness experience until after discharge
from the hospital, with concerns becoming apparent only
after the acute event.
We report 5 major findings. First, it was common for
participants to seek help from other health care sources
before presentation to the ED. Second, discordance
sometimes exists between the objective interpretation of
troponin results by clinicians and the ongoing illness
episode experienced by patients. Third, pretest
information, trust in the clinician, and active listening may
enhance reassurance gained from negative test results.
These first 3 themes were common to participants assessed
with both care pathways. Fourth, other themes appeared to
relate to the specific care pathway used; routine care
procedures appeared to be a source of frustration for
participants requiring admission to the hospital for serial
blood sampling. This frustration was not evident with the
early rule-out pathway. Fifth, patients assessed with the
early rule-out pathway appeared less likely to appraise their
future health status; therefore, the rapid rule-out of
myocardial infarction in the ED may provide less incentive
for patients to use their chest pain presentation as an
opportunity to address their future health.
The concepts of discordance and reassurance are linked,
with reassurance being more difficult to achieve when
discordance is present. Reassurance, diagnosis, explanation,Annals of Emergency Medicine 9
Patient Experience of Chest Pain Ferry et aland advice are the main interventions reducing suffering for
patients in the ED.31 The need for reassurance, and
therefore the use of mechanisms for the development of
reassurance, emerged as a key theme in this study. We
propose a model (Figure 2) in which communication
interventions incorporate the provision of pretest
information in regard to troponin testing, active listening,
and acknowledgment of the patient’s illness concerns. This
should lead to the development of trust between the
clinician and patient and may aid patients in considering
their illness episode as concluded and therefore feeling
reassured.
The benefit of pretest information in promoting
reassurance is supported by several randomized controlled
studies.32-34 In addition, verbal information has been
shown to be more effective than written information in
providing reassurance from negative exercise test results for
patients with chest pain.33 Many studies support the idea
that, for patients, a negative test result in itself may not be
reassuring.35-38 Patients may be ill prepared for negative or
normal findings; therefore, giving information before initial
blood sampling about the meaning and subsequent care
procedures related to troponin testing may aid in preparing
patients for the idea of direct discharge from the ED.
The absence of evidence of active listening was common
in accounts of patients who were not reassured by the chest
pain assessment process. A shared perspective between the
patient and clinician on the cause of symptoms and course
of action is positively associated with resolution of
symptoms.39 This requires effective communication and
recognition of the problem as expressed by the patient.
Without this, a patient may believe himself or herself ill
equipped to manage ongoing symptoms. Achieving a
shared understanding can be difficult because clinicians and
patients often understand health and illness through
different lenses.40 This is evident by the clinician’s ability to
interpret a low troponin concentration and rule-out of
myocardial infarction as a conclusion to the illness episode,
which can nonetheless remain very current to the patient.
The patient-clinician relationship can be strengthened
when patients have the opportunity to express their
concerns and the clinician shows empathy with and
responds to individual circumstances. When these critical
points in communication break down, trust is lost and
uncertainty for the patient may prevail. It appeared that
patients’ trust in their clinician had to be earned through
effective communication. Patients interpret reassurance in
the context of their own views and illness perceptions;
therefore, a key to successful reassurance is the clinician’s
ability to identify and acknowledge the patient’s
perspectives in regard to his or her symptoms and related10 Annals of Emergency Medicineconcerns. When there is failure to give credence to the
patient’s perspective, or the clinician’s view contradicts the
patient’s view, reassurance is difficult to achieve.41 When
the interventions of pretest information, active listening,
and development of trust have been satisfied, patients are
more likely to view their illness episode as complete.
The development of reassurance could also be hindered
by patient interpretation of routine care procedures. The
questionnaire study by Hancock and Carlton30 suggested
that patients would gain reassurance from being admitted
to the hospital, yet the evidence from the study reported
here has suggested that admission to the hospital may serve
to validate that symptoms may be serious, at least for some
patients. Additionally, it was rare for a patient to make the
decision to attend the hospital for assessment
independently without previous contact with the health
service. Prompts by a medical professional allow the patient
to negotiate access to care and construct attendance at the
ED as an appropriate action. If symptoms have been
validated by a health professional in this way, then
reassurance from the hospital assessment procedures may
be more difficult to achieve.
The risk of implementing early rule-out pathways is that
they may focus on process-driven care and outcomes (such
as complying with the target to admit, transfer, or discharge
patients within 4 hours of attendance at the ED) rather
than offering a comprehensive care experience to patients.
Although patients may accept that the main aim of an
assessment is to exclude a serious illness, care can be
considered lacking when it fails to address the patient as a
whole. Patients view talking to a professional about their
situation as an intervention as important as the delivery of
negative test results.16 Clinical history taking represents a
“process” of care in the ED. The frustration of repeating
the symptom presentation story, which was highly
prevalent among patients admitted to the hospital for serial
troponin-level testing and appeared infrequently among
those assessed with the early rule-out pathway, exemplifies
further that it is the active listening by the clinician and not
simply the opportunity to tell the story that is important to
patients.
A further concern about implementing an early rule-out
pathway is that the accelerated assessment process may
provide less of an opportunity for patients to consider their
future health than previous assessment approaches. An
episode of acute chest pain can serve as a cue to action for
this patient population (although we acknowledge that
interview participants revealed only an intention to act). It
is possible that the cue to action in the early rule-out
pathway is less persuasive because symptoms are dismissed
by the ED clinician much more quickly. These interviewVolume -, no. - : - 2019
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consideration of future health goals appears to be a reactive
rather than a proactive process.42 A clinical consultation
may therefore be enriched by harnessing this cue to action
and providing a teachable moment to increase perception
of personal risk to future ill health. The content of the
consultation may shape the perceived threat of disease or
belief in the benefit of lifestyle interventions for the patient.
The early rule-out pathway, with its focus on the rapid
rule-out of myocardial infarction, may not afford the
opportunity for this interaction to develop.
In summary, early rule-out pathways will undoubtedly
be of major benefit to health care providers by decreasing
unnecessary hospital admissions. Avoiding hospitalization
and having fewer health care professionals involved in the
assessment process were also viewed positively by patients.
The successful implementation of these pathways in the
ED will be aided by the addition of simple communication
interventions during the chest pain assessment process.
Confirmation of the absence of an acute cardiac event may
not satisfy the care needs of patients. To enhance the care
experience of patients presenting to the ED with symptoms
of suspected acute coronary syndrome, focus must remain
on the comprehensive assessment and care of the patient,
and not solely on the rule-out of myocardial infarction.
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